Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lacosamide added to current therapy in children with epilepsy syndromes presenting generalized seizures; results posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2019-05-07